Financing
Net change in commercial paper
Thermo Fisher Scientific Net change in commercial paper remained flat by 0.0% to $273.75M in Q4 2025 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ3 2025
How to read this metric
Increased reliance on commercial paper may signal tight cash flow or seasonal working capital needs.
Detailed definition
This represents the net change in short-term unsecured debt obligations issued by the company to meet immediate working...
Peer comparison
Standard for large-cap companies with high credit ratings and active treasury operations.
Metric ID:
cf_commercial_paper_netHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $1.26B | $2.23B | $200.00M | $0.00 | $523.00M | $918.00M | $494.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $273.75M | $273.75M | $273.75M | $273.75M |
| QoQ Change | — | — | — | — | +77.2% | -91.0% | -100.0% | — | +75.5% | -46.2% | -100.0% | — | — | — | — | — | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | — | — | -58.5% | -58.9% | +147.0% | — | -100.0% | -100.0% | -100.0% | — | — | — | — | — |
Range$0.00 – $2.23B
Avg YoY Growth-45.1%
Median YoY Growth-79.4%
Current Streak3+ quarters growth
Net change in commercial paper at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's net change in commercial paper?
- Thermo Fisher Scientific (TMO) reported net change in commercial paper of $273.75M in Q4 2025.
- What does net change in commercial paper mean?
- The net increase or decrease in short-term debt issued to fund operations.